Page last updated: 2024-10-31

metoprolol and Pulmonary Arterial Remodeling

metoprolol has been researched along with Pulmonary Arterial Remodeling in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
" Nebivolol was more potent than metoprolol in improving cardiac function, pulmonary vascular remodeling, and inflammation of rats with monocrotaline-induced pulmonary hypertension."3.81Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. ( Antigny, F; Bentebbal, S; Bogaard, HJ; Dorfmüller, P; Eddahibi, S; Fadel, E; Happé, C; Humbert, M; Izikki, M; Jourdon, P; Lecerf, F; Perros, F; Ranchoux, B; Simonneau, G, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perros, F1
Ranchoux, B1
Izikki, M1
Bentebbal, S1
Happé, C1
Antigny, F1
Jourdon, P1
Dorfmüller, P1
Lecerf, F1
Fadel, E1
Simonneau, G1
Humbert, M1
Bogaard, HJ1
Eddahibi, S1

Other Studies

1 other study available for metoprolol and Pulmonary Arterial Remodeling

ArticleYear
Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Journal of the American College of Cardiology, 2015, Feb-24, Volume: 65, Issue:7

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzopyrans; Cell Communication; Cell Culture Techn

2015